White paper: Approaches to alleviating subcutaneous pain at injection sites

Feb. 20, 2024
High concentration mAbs can create challenges for subcutaneous injection, namely pain at the injection site. This peer-reviewed article compares buffer formulation options, and an excipients selection strategy, in reducing injection-site pain.

mAbs delivered via subcutaneous (SC) injection provide numerous patient benefits and are currently the most common route of self-administered drugs. Yet these therapies must be formulated at high concentration, which may cause increased injection-site pain.

This article will discuss the use of citrate in SC formulations as compared to other buffers, as well as a formulation and excipients selection strategy that can be used to mitigate the risk of injection-site pain due to buffer, pH, and viscosity.

This content is sponsored by:

Latest

July 23, 2025
Watch this video to see how the OnTrak Wireless system provides a comprehensive solution for bearing health, monitoring ultrasound, vibration, and temperature, and offering autonomous...
July 23, 2025
Explore the OnTrak Wireless brochure, unifying bearing health monitoring and automatic precision lubrication in one wireless solution for superior asset management.
July 23, 2025
Read how Attindas Hygienic Partners used remote condition-based lubrication and the OnTrak system to identify a critical bearing defect and avert catastrophic failure, ensuring...
July 23, 2025
Learn how OnTrak Wireless harnesses the power of ultrasound to detect bearing faults in recirculation fans a full month earlier than traditional vibration monitoring, preventing...